| 臺大學術典藏 |
2021-01-28T02:02:55Z |
A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma
|
Hsu F.-S.;Su C.-H.;Kuo-How Huang; Hsu F.-S.; Su C.-H.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:55Z |
The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: A hypothesis generating pilot study
|
Wu V.-C.;Wu C.-H.;Yang Y.-W.;Kuo-How Huang;Chang C.-H.;Yang S.-Y.;Lin Y.-H.;Wu K.-D.;The Nrpb Kidney Consortium; Wu V.-C.; Wu C.-H.; Yang Y.-W.; KUO-HOW HUANG; Chang C.-H.; Yang S.-Y.; Lin Y.-H.; Wu K.-D.; The NRPB Kidney Consortium |
| 臺大學術典藏 |
2021-01-28T02:02:54Z |
Comparative analysis between radical cystectomy and trimodality therapy for clinical stage II bladder cancer - Experience from a tertiary referral center
|
Hong J.-H.;Lin Y.-H.;Lu Y.-C.;Chiang Y.;Tai H.-C.;Kuo-How Huang;Cheng C.-H.;Pu Y.-S.; Hong J.-H.; Lin Y.-H.; Lu Y.-C.; Chiang Y.; Tai H.-C.; KUO-HOW HUANG; Cheng C.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:02:54Z |
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
|
Wu V.-C.;Wang S.-M.;Chueh S.-C.J.;Yang S.-Y.;Kuo-How Huang;Lin Y.-H.;Wang J.-J.;Connolly R.;Hu Y.-H.;Gomez-Sanchez C.E.;Peng K.-Y.;Wu K.-D.; Wu V.-C.; Wang S.-M.; Chueh S.-C.J.; Yang S.-Y.; KUO-HOW HUANG; Lin Y.-H.; Wang J.-J.; Connolly R.; Hu Y.-H.; Gomez-Sanchez C.E.; Peng K.-Y.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-28T02:02:54Z |
Factors associated with reoperation in hypospadias surgery — A nationwide, population-based study
|
Lu Y.-C.;Huang W.-Y.;Chen Y.-F.;Chang H.-C.;Pong Y.-H.;Shih T.-H.;Kuo-How Huang; Lu Y.-C.; Huang W.-Y.; Chen Y.-F.; Chang H.-C.; Pong Y.-H.; Shih T.-H.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:53Z |
Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity
|
Chao S.-C.;Chen Y.-J.;Kuo-How Huang;Kuo K.-L.;Yang T.-H.;Huang K.-Y.;Wang C.-C.;Tang C.-H.;Yang R.-S.;Liu S.-H.; Chao S.-C.; Chen Y.-J.; KUO-HOW HUANG; Kuo K.-L.; Yang T.-H.; Huang K.-Y.; Wang C.-C.; Tang C.-H.; Yang R.-S.; Liu S.-H. |
| 臺大學術典藏 |
2021-01-28T02:02:53Z |
Case detection and diagnosis of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Wu V.-C.;Hu Y.-H.;Er L.K.;Yen R.-F.;Chang C.-H.;Chang Y.-L.;Lu C.-C.;Chang C.-C.;Lin J.-H.;Lin Y.-H.;Wang T.-D.;Wang C.-Y.;Tu S.T.;Jeff Chueh S.-C.;Tseng F.-Y.;Wu K.-D.;Wang W.-J.;Wu C.-H.;Ho Y.-L.;Lin L.-Y.;Hu Y.-H.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Kuo-How Huang;Liao S.-C.;Taipai Group; Wu V.-C.; Hu Y.-H.; Er L.K.; Yen R.-F.; Chang C.-H.; Chang Y.-L.; Lu C.-C.; Chang C.-C.; Lin J.-H.; Lin Y.-H.; Wang T.-D.; Wang C.-Y.; Tu S.T.; Jeff Chueh S.-C.; Tseng F.-Y.; Wu K.-D.; Wang W.-J.; Wu C.-H.; Ho Y.-L.; Lin L.-Y.; Hu Y.-H.; Hu F.-C.; Liu K.-L.; Wang S.-M.; KUO-HOW HUANG; Liao S.-C.; TAIPAI group |
| 臺大學術典藏 |
2021-01-28T02:02:52Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.;Liu K.-L.;Chou P.-M.;Lin W.-C.;Tai H.-C.;Huang C.-Y.;Wang S.-M.;Kuo-How Huang;Pu Y.-S.; Lien C.-C.; Liu K.-L.; Chou P.-M.; Lin W.-C.; Tai H.-C.; Huang C.-Y.; Wang S.-M.; KUO-HOW HUANG; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:02:52Z |
Comparison of C-arm computed tomography and on-site quick cortisol assay for adrenal venous sampling: A retrospective study of 178 patients
|
Chang C.-C.;Lee B.-C.;Chang Y.-C.;Wu V.-C.;Kuo-How Huang;Liu K.-L.;On Behalf Of The Taipai Study Group; Chang C.-C.; Lee B.-C.; Chang Y.-C.; Wu V.-C.; KUO-HOW HUANG; Liu K.-L.; on behalf of the TAIPAI Study Group |
| 臺大學術典藏 |
2021-01-28T02:02:52Z |
Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle
|
Tseng C.-S.;Chiang I.-N.;Hong C.-H.;Lu Y.-C.;Hong J.-H.;Chang H.-C.;Kuo-How Huang;Pu Y.-S.; Tseng C.-S.; Chiang I.-N.; Hong C.-H.; Lu Y.-C.; Hong J.-H.; Chang H.-C.; KUO-HOW HUANG; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:02:51Z |
Impact of high-volume disease in Asian population with newly diagnosed metastatic prostate cancer
|
Cheng Y.-T.;Hong J.-H.;Lu Y.-C.;Pu Y.-S.;Huang C.-Y.;Kuo-How Huang;Liu S.;Chen C.-H.; Cheng Y.-T.; Hong J.-H.; Lu Y.-C.; Pu Y.-S.; Huang C.-Y.; KUO-HOW HUANG; Liu S.; Chen C.-H. |
| 臺大學術典藏 |
2021-01-28T02:02:51Z |
Do transperitoneal and retroperitoneal hand-assisted laparoscopic nephroureterectomy have different effects on intravesical recurrence?
|
Hu C.-Y.;Huang C.-Y.;Kuo-How Huang;Tai H.-C.;Lin Y.-M.;Tai T.-Y.; Hu C.-Y.; Huang C.-Y.; KUO-HOW HUANG; Tai H.-C.; Lin Y.-M.; Tai T.-Y. |
| 臺大學術典藏 |
2021-01-28T02:02:51Z |
Comparative analysis between radical cystectomy and trimodality therapy for clinical Stage II Bladder Cancer: Experience from a tertiary referral center
|
Hong J.-H.;Lin Y.-H.;Lu Y.-C.;Chiang Y.;Tai H.-C.;Kuo-How Huang;Cheng C.-H.;Pu Y.-S.; Hong J.-H.; Lin Y.-H.; Lu Y.-C.; Chiang Y.; Tai H.-C.; KUO-HOW HUANG; Cheng C.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:02:51Z |
Outcomes of prostate atypical small acinar proliferation and high-grade prostate intraepithelial neoplasm patients
|
Tung S.-Y.;Pu Y.-S.;Huang C.-Y.;Chang H.-C.;Kuo-How Huang;Wang S.-M.;Tai H.-C.;Chen C.-H.; Tung S.-Y.; Pu Y.-S.; Huang C.-Y.; Chang H.-C.; KUO-HOW HUANG; Wang S.-M.; Tai H.-C.; Chen C.-H. |
| 臺大學術典藏 |
2021-01-28T02:02:50Z |
Gonadectomy in patients with disorder of sexual development
|
Chen K.-T.;Tai Y.-S.;Chiang I.-N.;Chang H.-C.;Kuo-How Huang; Chen K.-T.; Tai Y.-S.; Chiang I.-N.; Chang H.-C.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:50Z |
MiRNA-203 modulates aldosterone levels and cell proliferation by targeting wnt5a in aldosterone-producing adenomas
|
Peng K.-Y.;Chang H.-M.;Lin Y.-F.;Chan C.-K.;Chang C.-H.;Chueh S.-C.J.;Yang S.-Y.;Kuo-How Huang;Lin Y.-H.;Wu V.-C.;Wu K.-D.; Peng K.-Y.; Chang H.-M.; Lin Y.-F.; Chan C.-K.; Chang C.-H.; Chueh S.-C.J.; Yang S.-Y.; KUO-HOW HUANG; Lin Y.-H.; Wu V.-C.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Kuo-How Huang;Lin Y.-H.;Wu V.-C.;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Wang S.-M.;Liao S.-C.;Lu C.-C.;Yen R.-F.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; KUO-HOW HUANG; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Primary aldosteronism and cerebrovascular diseases
|
Chen Z.-W.;Hung C.-S.;Wu V.-C.;Lin Y.-H.;Wu C.-H.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Kuo-How Huang;Chen Y.-M.;Chang C.-C.;Liao S.-C.;Yen R.-F.;Wu K.-D.; Chen Z.-W.; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; KUO-HOW HUANG; Chen Y.-M.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:48Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Kuo-How Huang;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; KUO-HOW HUANG; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-01-28T02:02:48Z |
The influence of the peripheral cortisol fluctuation on the success rate of adrenal venous sampling
|
Chang C.-C.;Lee B.-C.;Liu K.-L.;Chang Y.-C.;Wu V.-C.;Kuo-How Huang;Wu T.-H.; Chang C.-C.; Lee B.-C.; Liu K.-L.; Chang Y.-C.; Wu V.-C.; KUO-HOW HUANG; Wu T.-H. |
| 臺大學術典藏 |
2021-01-28T02:02:47Z |
Is prophylactic nasogastric tube decompression necessary in patients undergoing laparoscopic adrenalectomy for unilateral benign adrenal tumor
|
Chen K.-T.;Wu V.-C.;Wu K.-D.;Kuo-How Huang; Chen K.-T.; Wu V.-C.; Wu K.-D.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:47Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.;Chiang C.-H.;Pu Y.-S.;Liu S.P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Kuo-How Huang;Lee Y.-J.;Chow P.-M.;Hung S.-C.;Huang C.-Y.; Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; KUO-HOW HUANG; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Chow P.-M.;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Kuo-How Huang; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; KUO-HOW HUANG |
